Vipivotide tetraxetan linker is formed by conjugating the pharmacophore glutamic acid-urea-lysine peptide with a linker, and is mainly used in the synthesis of vipivotide tetraxetan (PSMA-617). The glutamic acid-urea-lysine motif specifically binds to prostate-specific membrane antigen (PSMA).
Molecular Weight:
655.74
Purity:
99.80%
CAS Number:
[1703768-74-4]
Formula:
C33H45N5O9
Target:
ADC Linker
T17233
T17233
* VAT and and shipping costs not included. Errors and price changes excepted